换一批Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort.
第一作者：
Danja,Sarink
第一单位：
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
作者：
Danja,Sarink [1]
;
Helena,Schock [1]
;
Theron,Johnson [1]
;
Jenny,Chang-Claude [1]
;
Kim,Overvad [2]
;
Anja,Olsen [3]
;
Anne,Tjønneland [3]
;
Patrick,Arveux [4]
;
Agnès,Fournier [5]
;
Marina,Kvaskoff [5]
;
Heiner,Boeing [6]
;
Anna,Karakatsani [7]
;
Antonia,Trichopoulou [8]
;
Carlo,La Vecchia [9]
;
Giovanna,Masala [10]
;
Claudia,Agnoli [11]
;
Salvatore,Panico [12]
;
Rosario,Tumino [13]
;
Carlotta,Sacerdote [14]
;
Carla H,van Gils [15]
;
Petra H M,Peeters [16]
;
Elisabete,Weiderpass [17]
;
Antonio,Agudo [18]
;
Miguel,Rodríguez-Barranco [19]
;
José María,Huerta [20]
;
Eva,Ardanaz [21]
;
Leire,Gil [22]
;
Kay Tee,Kaw [23]
;
Julie A,Schmidt [24]
;
Laure,Dossus [25]
;
Mathilde,His [25]
;
Dagfinn,Aune [26]
;
Elio,Riboli [26]
;
Rudolf,Kaaks [1]
;
Renée T,Fortner [27]
作者单位：
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
[1]
Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark.
[2]
Danish Cancer Society Research Center, Copenhagen, Denmark.
[3]
Breast and Gynaecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Comprehensive Cancer Care Centre, Dijon, France.;Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France.;Gustave Roussy, Villejuif, France.
[4]
Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, INSERM, Villejuif, France.;Gustave Roussy, Villejuif, France.
[5]
Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
[6]
Hellenic Health Foundation, Athens, Greece.;2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Athens, Greece.
[7]
Hellenic Health Foundation, Athens, Greece.;WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
[8]
Hellenic Health Foundation, Athens, Greece.;Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
[9]
Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute - ISP, Florence, Italy.
[10]
Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
[11]
Dipartimento di Medicine Clinica e Chirurgia, Federico II University, Naples, Italy.
[12]
Cancer Registry and Histopathology Department, "Civic M.P.Arezzo" Hospital, Azienda Sanitaria Provinciale, Ragusa, Italy.
[13]
Unit of Cancer Epidemiology, Città della Salute e della Scienza University Hospital and Center for Cancer Prevention (CPO), Turin, Italy.
[14]
Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
[15]
Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.;MRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, UK.
[16]
Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.;Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.;Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.;Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland.
[17]
Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
[18]
Escuela Andaluza de Salud Pública. Instituto de Investigación Biosanitaria ibs.GRANADA, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain.;CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
[19]
CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.;Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
[20]
CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.;Navarra Public Health Institute, Pamplona, Spain.;IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
[21]
Public Health Division of Gipuzkoa, Biodonostia Health Research Institute, San Sebastian, Spain.
[22]
Cancer Epidemiology Unit, University of Cambridge, Cambridge, UK.
[23]
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
[24]
International Agency for Research on Cancer, Lyon, France.
[25]
Department of Epidemiology and Biostatistics, The School of Public Health, Imperial College London, London, UK.
[26]
Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany. r.fortner@dkfz.de.
[27]
主题词
成年人(Adult);老年人(Aged);乳腺肿瘤(Breast Neoplasms);病例对照研究(Case-Control Studies);队列研究(Cohort Studies);女(雌)性(Female);人类(Humans);检测限(Limit of Detection);中年人(Middle Aged);骨保护素(Osteoprotegerin);预后(Prognosis);RANK配体(RANK Ligand);危险(Risk)
DOI
10.1186/s12885-018-4887-3
PMID
30348163
发布时间
2025-05-30
- 浏览27
BMC cancer
BMC cancer
1010页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
